A study by Zhang et al. demonstrated that lncRNA RPL34-AS1 potentially serve as a valuable diagnostic and prognostic biomarker and therapeutic target in patients with brain glioma (Zhang et al., 2021). Here, RPL34 is linked to brain glioma.